𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Integration of irinotecan and cisplatin with early concurrent conventional radiotherapy for limited-disease SCLC (LD-SCLC)

✍ Scribed by Sherif Abdelwahab; Hatem Abdulla; Ali Azmy; Ahmed Abdelfatah; Hany Abdel-Aziz; Maha Margerges; Atef Riad; Vinay Sharma; Ibrahim Dwedar

Publisher
Springer
Year
2009
Tongue
English
Weight
253 KB
Volume
14
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of irinotecan and cisplat
Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer
✍ Joo Hyuk Sohn; Yong Wha Moon; Chang Geol Lee; Gwi Eon Kim; Kyung Young Chung; Jo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## BACKGROUND. A Phase II trial of irinotecan and cisplatin (IP) with early concurrent radiotherapy was performed in limited‐disease small‐cell lung cancer (LD‐SCLC) to evaluate the efficacy and toxicity. ## METHODS. For untreated LD‐SCLC patients, irinotecan (60 mg/m^2^, Days 1, 8,